Please login to the form below

Not currently logged in
Email:
Password:

Tony de Fougerolles joins Evox Therapeutics as CEO

He succeeds Dr Per Lundin who stays at the firm as COO

TonyOxford, UK-based Evox Therapeutics has appointed its new chief executive officer in the form of Tony de Fougerolles.

He succeeds Dr Per Lundin who will continue in his role as chief operating officer of the biotherapeutics company, overseeing operational aspects of its business as well as advancing and expanding the company’s intellectual property estate.

Dr Lundin said: “After a thorough selection process, I am incredibly pleased that Tony is joining the team as we continue to develop Evox into the world’s leading exosome therapeutics company.

“Tony has an outstanding track record in progressing products through the pipeline and a strong scientific understanding.

“He has also been integral to his previous companies’ deal-making success and we are exciting for him to bring such extensive experience to Evox.”

Fougerolles joins the company from Ablynx, where he held the role of chief scientific officer for four years expanding its pipeline and forming new partnerships.

Prior to this, he was chief scientific officer at Moderna Therapeutics and has held the same role at Tolerx.

He said: “Having worked as a chief scientific officer for seven years, I appreciate the fine balance between developing new drug platforms, advancing a therapeutic pipeline, and building the business.

“I believe we can progress through the clinic an entirely novel class of biotherapeutics and I look forward to working with Per and the rest of the board to develop therapies with a potentially transformative impact on the lives of patients suffering from severe illnesses.”

22nd November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics